Finally, to compare the wild-type and Arid2-deleted CD8+ T cell response independent of the tumor volume, we cotransferred an equal number of congenic sgCtrl and sgArid2 P14 CD8+ T cells into B16-GP33-bearing recipient mice (Figure S6H). This evidence concerns the gene ARID2 and neoplasm.